DE69119031D1 - Diarylmethoxypiperidin-Derivate - Google Patents

Diarylmethoxypiperidin-Derivate

Info

Publication number
DE69119031D1
DE69119031D1 DE69119031T DE69119031T DE69119031D1 DE 69119031 D1 DE69119031 D1 DE 69119031D1 DE 69119031 T DE69119031 T DE 69119031T DE 69119031 T DE69119031 T DE 69119031T DE 69119031 D1 DE69119031 D1 DE 69119031D1
Authority
DE
Germany
Prior art keywords
methoxypiperidine
diaryl
derivatives
methoxypiperidine derivatives
diaryl methoxypiperidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69119031T
Other languages
English (en)
Other versions
DE69119031T2 (de
Inventor
Jun Ichiro Kita
Shinji Takamura
Kayoko Yamano
Hiroshi Fujiwara
Hiroko Honda
Kumiko Murata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ube Corp
Original Assignee
Ube Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ube Industries Ltd filed Critical Ube Industries Ltd
Application granted granted Critical
Publication of DE69119031D1 publication Critical patent/DE69119031D1/de
Publication of DE69119031T2 publication Critical patent/DE69119031T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/46Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE69119031T 1990-11-15 1991-11-13 Diarylmethoxypiperidin-Derivate Expired - Fee Related DE69119031T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2307190A JP2624372B2 (ja) 1990-11-15 1990-11-15 ジアリールメトキシピペリジン誘導体

Publications (2)

Publication Number Publication Date
DE69119031D1 true DE69119031D1 (de) 1996-05-30
DE69119031T2 DE69119031T2 (de) 1996-11-14

Family

ID=17966130

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69119031T Expired - Fee Related DE69119031T2 (de) 1990-11-15 1991-11-13 Diarylmethoxypiperidin-Derivate

Country Status (4)

Country Link
US (1) US5225559A (de)
EP (1) EP0485984B1 (de)
JP (1) JP2624372B2 (de)
DE (1) DE69119031T2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231104A (en) * 1988-07-08 1993-07-27 Pfizer Inc. 1-arylethyl-3-substituted piperidines
US5190959A (en) * 1991-08-08 1993-03-02 Kaken Pharmaceutical Co. Ltd. Piperidine compounds which have useful pharmaceutical activity
HUT63843A (en) * 1992-02-13 1993-10-28 Biosignal Kutato Fejlesztoe Kf Process for producing new kumarin derivatives and their analogs inhibiting mammal cell proliferation and tumour growth, as well as pharmaceutical comkpositions comprising such compounds
JP3193508B2 (ja) * 1993-03-05 2001-07-30 興和株式会社 ピペリジン誘導体
JP3779349B2 (ja) * 1995-04-24 2006-05-24 興和株式会社 ピペリジン誘導体
TW486475B (en) 1996-12-26 2002-05-11 Ube Industries Acid addition salt of optically active piperidine compound and process for preparing the same
JP3107784B2 (ja) * 1996-12-26 2000-11-13 宇部興産株式会社 光学活性ピペリジン誘導体の酸付加塩及びその製法
US7355042B2 (en) * 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US7189757B2 (en) * 2001-10-16 2007-03-13 Hypnion, Inc. Treatment of sleep disorders using CNS target modulators
AU2002347906A2 (en) * 2001-10-16 2003-04-28 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US7094914B2 (en) 2002-02-28 2006-08-22 Sumitomo Chemical Company, Limited Process for producing chromone compound
KR100879409B1 (ko) * 2007-06-11 2009-01-19 한미약품 주식회사 (s)-베포타스틴의 제조방법 및 이에 사용되는 중간체
JP5761173B2 (ja) * 2010-03-04 2015-08-12 味の素株式会社 糖尿病又は肥満症の予防又は治療剤
BR112012021657B8 (pt) * 2010-03-04 2022-06-07 Ea Pharma Co Ltd Composto, agente farmacêutico, agente para conferir kokumi , e, tempero

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB688354A (en) * 1950-04-07 1953-03-04 Nopco Chem Co Improvements relating to compounds of the benzhydryl ether type
FR2081579B1 (de) * 1970-03-18 1973-04-06 Delalande Sa
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
JPS61194068A (ja) * 1985-02-21 1986-08-28 Terumo Corp ビニル誘導体およびこれを含有する5−リポキシゲナ−ゼ作用阻害剤
JPS61254559A (ja) * 1985-05-07 1986-11-12 Terumo Corp ビニル誘導体およびこれを含有する5−リポキシゲナ−ゼ作用阻害剤
JPS625956A (ja) * 1985-07-02 1987-01-12 Terumo Corp ビニル誘導体およびこれを含有する5−リポキシゲナ−ゼ作用阻害剤
US4929618A (en) * 1988-03-25 1990-05-29 Ube Industries, Ltd. Piperdine and piperazine derivatives, and antihistaminic pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
JP2624372B2 (ja) 1997-06-25
EP0485984A2 (de) 1992-05-20
US5225559A (en) 1993-07-06
DE69119031T2 (de) 1996-11-14
EP0485984B1 (de) 1996-04-24
JPH04182467A (ja) 1992-06-30
EP0485984A3 (en) 1993-01-20

Similar Documents

Publication Publication Date Title
DE69119329D1 (de) Actinonin-Derivate
FI925523A0 (fi) Hydroxi- och alkoxipyridinderivat
ATA150090A (de) Hoergeraet
DE69125099D1 (de) Indolderivate
ATE144765T1 (de) Hiv-hemmende benzenacetamidderivate
ATE171449T1 (de) Oxadolderivate
DE59107315D1 (de) Einzelmode-laser
DK0472733T3 (da) Phenantrenderivater
TR26336A (tr) SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
FI930894A (fi) Form foer flotationsprodukter
DE69119031D1 (de) Diarylmethoxypiperidin-Derivate
ATA210290A (de) Lotpille
ATA80690A (de) Alpinschi
BR9104543A (pt) Derivados de triazolpiridazina
ATA200090A (de) Pianino
ATA237490A (de) Rinnenstein
ATA209290A (de) Diaraehmchen
BR9002505A (pt) Venturbo
BR9003611A (pt) Hidrobaliador
DK80790A (da) Thien-triazol-diazepin-derivater
BR7000286U (pt) Barraca-bagageiro
BR7001930U (pt) Terrario
BR7000491U (pt) Loteria zoonumerica futebolistica
BR7000495U (pt) Disjuntor salva-vidas
BR7000649U (pt) Autoar

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee